PHARMACEUTICALS Archives

China's Medtech Volume-Based Procurement Big Savings, Bigger Challenges by EOS Implicium

China VBP: Turning Down the Volume on MedTech Margins

22/10/2025by EOS Intelligence

China’s phased rollout of Volume-Based Procurement (VBP), which started in the pharmaceutical industry in 2018, quickly expanded to the medical devices market in 2019. VBP standardizes medical device prices in...

Pet and Animal Health M&A: What’s the Scoop on the Industry’s Latest Shake-ups?

27/02/2025by EOS Intelligence

The pet and animal health market has seen a recent surge in M&A, signaling shifting dynamics within the industry. While rising pet ownership and increasing pet care awareness are creating...

New Directions in Alzheimer’s Diagnostics: Will Blood Tests Replace CSF and PET?

30/09/2024by EOS Intelligence

Around three-fourths of dementia cases continue to remain undiagnosed even though the incidence of Alzheimer’s disease (AD) is rapidly growing across the globe. AD affects about 60-80% of dementia patients...

Phase 3 Drug Candidates – A Ray of Hope in Alzheimer’s Disease Bleak Treatment Landscape?

26/09/2024by EOS Intelligence

Many biopharmaceutical companies, such as AriBio, Annovis Bio, Athira Pharma, Cassava Sciences, and Alzheon, specializing in treating neurodegenerative diseases, are developing drugs for Alzheimer’s disease (AD) that are currently in...

Pharma Companies Navigate Their Way through Ac-225 amidst Supply Constraints

19/09/2024by EOS Intelligence

Pharma companies have been increasingly investing in developing targeted alpha therapies for cancer treatment, using alpha-emitting isotopes such as Ac-225. However, the current supply for Ac-225 is limited, and thus,...

IRA: Are Patients Winning at the Cost of the US Pharma Sectoral Growth?

20/06/2024by EOS Intelligence

The market reaction to the US Inflation Reduction Act of 2022 is mostly mixed. It is expected to change the pharma industry dynamics in terms of the competitive positioning and...

Denmark – A Trailblazer in Digital Health Innovation

06/06/2024by EOS Intelligence

The COVID-19 pandemic has spurred the need to embrace new digital tools and technologies within the healthcare sector. There has been a significant increase in the use of technology to...

An Era of Innovation: Novel Drugs Redefining Multiple Sclerosis Treatment Paradigm

30/05/2024by EOS Intelligence

Since the approval of the first drug, interferon beta 1b (IFNβ-1b), in 1993, the treatment landscape of multiple sclerosis (MS) has significantly changed. Currently, there exist more than 20 disease-modifying...

Who We Are

Connect With Us

Work With EOS